18 completed, 2 not yet recruiting, 2 recruiting, 1 active not recruiting. 25 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 25 | Completed 18, Not yet recruiting 2, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency Nebido (Testosterone Undecanoate) - Frail Elderly Patients, Hypogonadal Males | Phase 2 | Not yet recruiting | Rune Skovgaard Rasmussen | 96 | 2026-08-01 | 2026-05-06 |
| An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD Oral Testosterone Undecanoate - Hypoactive Sexual Desire Disorder | Phase 2 | Not yet recruiting | San Diego Sexual Medicine | 30 | 2025-01-01 | 2024-11-13 |
| Does Human Skeletal Muscle Possess an Epigenetic Memory of Testosterone? Saline, Testosterone Undecanoate, Saline + Resistance exercise training - Healthy Aging, Age-Related Sarcopenia | Phase 2 / Phase 3 | Completed | Norwegian School of Sport Sciences | 45 | 2024-09-01 | 2026-03-06 |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male | Phase 1 / Phase 2 | Unknown | University of Washington | 10 | 2024-06-01 | 2024-03-15 |
| Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer Testosterone Undecanoate, Enzalutamide - Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 15 | 2022-03-07 | 2026-09-29 |
| Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism Testosterone Undecanoate 250 MG/ML, Placebo - Opioid Use, Pain | Phase 2 | Recruiting | Brigham and Women's Hospital | 150 | 2022-01-10 | 2026-07-27 |
| Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], placebo - Hypogonadism, Male, Fatigue Syndrome, Chronic | Phase 2 | Recruiting | Seattle Institute for Biomedical and Clinical Research | 240 | 2021-03-22 | 2026-06-22 |
| A Study of the Safety and Tolerability of LPCN 1144 in Subjects Who Completed the LPCN 1144-18-002 Trial LPCN 1144 - NASH - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Lipocine Inc. | 25 | 2020-11-11 | 2024-07-17 |
| The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis LPCN 1144 Formulation A, LPCN 1144 Formulation B, Placebo - Nonalcoholic Steatohepatitis (NASH) | Phase 2 | Completed | Lipocine Inc. | 56 | 2019-08-27 | 2023-12-14 |
| Multimodality Intervention for Function and Metabolism in SCI Testosterone Undecanoate, hybrid exercise - Spinal Cord Injuries | Phase 2 | Completed | Brigham and Women's Hospital | 84 | 2019-08-23 | 2026-05-07 |
| The Effect of Various Amounts of Fat on PK of Oral Testosterone Undecanoate Oral Testosterone Undecanoate - Hypogonadism | Phase 2 | Completed | Clarus Therapeutics, Inc. | 18 | 2016-10-01 | 2018-05-17 |
| Testosterone in Metastatic Renal Cell Carcinoma Patients Testosterone undecanoate and sunitinib or pazopanib - Metastatic Renal Cell Carcinoma | Phase 2 | Completed | Kidney Cancer Research Bureau | 60 | 2016-02-08 | 2019-10-22 |
| Phlebotomy Study of Testosterone Undecanoate Oral Testosterone Undecanoate - Hypogonadism | Phase 1 / Phase 2 | Completed | Clarus Therapeutics, Inc. | 8 | 2016-01-01 | 2018-03-09 |
| Testosterone Replacement in Non-alcoholic Steatohepatitis (TEREPINS) testosterone undecanoate - Nonalcoholic Steatohepatitis, Hypogonadism | Phase 2 | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 3 | 2013-07-01 | 2017-04-26 |
| Effectiveness of Testosterone Undecanoate to Improve Sexual Function in Postmenopausal Women Testosterone undecanoate, placebo - Female Sexual Dysfunction | Phase 2 | Completed | Chulalongkorn University | 70 | 2012-06-01 | 2014-01-29 |
| Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients Testosterone undecanoate, placebo - Multiple Sclerosis, Fatigue | Phase 2 | Terminated | Health Sciences Centre, Winnipeg, Manitoba | 3 | 2012-02-01 | 2014-07-08 |
| Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation Oral testosterone undecanoate (containing 300 mg T) - Male Hypogonadism | Phase 2 | Completed | Clarus Therapeutics, Inc. | 16 | 2009-07-01 | 2020-12-02 |
| Pharmacokinetic Study to Determine Time to Steady-state Testosterone undecanoate - Male Hypogonadism, Primary Hypogonadism | Phase 2 | Completed | Clarus Therapeutics, Inc. | 15 | 2009-07-01 | 2020-12-11 |
| Androgen for Leydig Cell Proliferation Testosterone undecanoate, Castor Oil - Klinefelter Syndrome, Hypergonadotropic Hypogonadism | Phase 2 / Phase 3 | Completed | University of Roma La Sapienza | 56 | 2009-06-01 | 2018-09-25 |
| Reandron in Diabetic Men Witn Low Testosterone Level Reandron 1000, placebo - Type 2 Diabetes, Hypogonadism | Phase 2 / Phase 3 | Completed | Austin Health | 88 | 2009-01-01 | 2014-07-01 |
Showing 20 of 25. Sign in to see all of them.
Hypogonadism (13) · Eunuchism (7) · Non-alcoholic Fatty Liver Disease (3) · Carcinoma, Renal Cell (1) · Coronary Disease (1) · Diabetes Mellitus, Type 2 (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Frailty (1) · Infertility (1) · Klinefelter Syndrome (1) · Multiple Sclerosis (1) · Pain (1) · Prostatic Neoplasms (1) · Sexual Dysfunctions, Psychological (1)
Clarus Therapeutics, Inc. (6) · Brigham and Women's Hospital (2) · Lipocine Inc. (2) · Austin Health (1) · Chulalongkorn University (1) · Health Sciences Centre, Winnipeg, Manitoba (1) · Imperial College London (1) · Kidney Cancer Research Bureau (1) · Merck Sharp & Dohme LLC (1) · Norwegian School of Sport Sciences (1) · Organon and Co (1) · Rune Skovgaard Rasmussen (1) · San Diego Sexual Medicine (1) · Seattle Institute for Biomedical and Clinical Research (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1)
United States (13) · Canada (2) · United Kingdom (2) · Australia (1) · Denmark (1) · Italy (1) · Norway (1) · Russia (1) · Thailand (1)
Anthony DelConte (2) · Andrea Isidori, MD, PhD (1) · Andrea Lenzi, MD (1) · Christina Wang, M.D. (1) · Dermot Gleeson, MD (1) · Gregory Flippo, M.D. (1) · Gregory Flippo, MD (1) · Irwin Goldstein, MD (1) · James J Marriott, MD (1) · John Amory, MD (1) · Jose M Garcia, MD, PhD (1) · Mathis Grossmann (1) · Mette Midttun, MD, DMSc (1) · Peter Collins, MA MD FRCP (1) · Reuthairat Tungmunsakulchai, MD (1)
PMID 21474786, PMID 12626215, PMID 18308009, PMID 18413423, PMID 23581697, PMID 24978674, PMID 26030346, PMID 26631095, PMID 31532522, PMID 35614404, PMID 38325649
R01HD093724 (1)